Diane Berson
Dermatology · New York, NYNPI 1184655078
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $28,872 of the $42,100 with a category attached, or 68.6%. It is spread thinly across 19 manufacturers, the largest accounting for just 17.0%. Reporting peaked in 2021 at $16,447 and has fallen 69.9% since, to $4,946 in 2025. Among dermatology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 79 payments — averaging $532.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$7K
- AbbVie$6K
- Sun Pharmaceutical Industries Inc.$5K
- Aclaris Therapeutics, Inc.$4K
- Almirall LLC$4K
- Dermira, Inc.$3K
- plus $12K from 13 others
What the payments were for
- Consulting fees$28,87269%
- Speaking & faculty fees$9,50023%
- Travel & lodging$1400%
- Food & beverage$3,4278%
- Education$1600%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $7,158 |
| AbbVie(2 entities) | 24 | $6,251 |
| Sun Pharmaceutical Industries Inc. | 11 | $5,018 |
| Aclaris Therapeutics, Inc. | 7 | $4,366 |
| Almirall LLC | 3 | $3,850 |
| Dermira, Inc. | 3 | $2,986 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $2,800 |
| Revance Therapeutics, Inc. | 3 | $2,780 |
| Botanix SB Inc | 1 | $2,200 |
| Novartis | 1 | $2,160 |
| EPI Health, LLC | 1 | $1,500 |
| Galderma Laboratories, L.p. | 11 | $480 |
| Biofrontera Inc. | 1 | $119 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $109 |
| Journey Medical Corporation | 1 | $96 |
| Incyte Corporation | 1 | $76 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Arcutis Biotherapeutics, Inc. | 1 | $58 |
| Merz North America, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rhofade$4,245
- Seysara$3,850
- Winlevi$3,200
- QBREXZA$2,936
- DAXXIFY$2,780
- SOFDRA$2,200
- COSENTYX$2,160
- BOTOX$1,717
- ABSORICA LD$1,702
- BOTOX COSMETIC$1,600
- WYNZORA$1,500
- ALTRENO$1,200
- AKLIEF$172
- SOOLANTRA$172
- EPIDUO FORTE$172
- AMELUZ$119
- BF-RhodoLED$119
- XEPI$119
- ILUMYA$102
- LEVULAN KERASTICK$102
How this compares
$42,100 in reported general payments places this provider in the 90th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 17 | $159 |
| Spironolactone | 11 | $6 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.